4.5 Article

Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study

期刊

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
卷 32, 期 12, 页码 1264-1271

出版社

WILEY
DOI: 10.1002/gps.4607

关键词

Alzheimer's disease; neuropsychiatric symptoms; psycho-social aspects; non-pharmacological therapy; aggression; psychosis

资金

  1. Asahi Kasei Pharma
  2. Astellas Pharmaceutical
  3. Daiichi Sankyo
  4. Dainippon-Sumitomo Pharma
  5. Eisai
  6. Eli Lilly
  7. GlaxoSmithKline
  8. Janssen Pharmaceutical
  9. Meiji-Seika Pharma
  10. Mochida Pharmaceutical
  11. MSD
  12. Novartis Pharma
  13. Otsuka Pharmaceutical
  14. Pfizer
  15. Shionogi
  16. Takeda
  17. Tanabe Mitsubishi Pharma
  18. Yoshitomi-Yakuhin

向作者/读者索取更多资源

ObjectiveThis study sought to determine psychosocial and clinico-demographic factors related to each symptomatic cluster (i.e., aggressiveness, psychosis, apathy/eating problems, and emotion/disinhibition) of neuropsychiatric symptoms (NPSs) in patients with Alzheimer's disease (AD) needing interventional treatment against their agitation or psychotic symptoms. These clusters were classified from 12 Neuropsychiatric Inventory (NPI) subscores in our previous study using the Clinical Antipsychotic Trials of Intervention EffectivenessAlzheimer's Disease (CATIE-AD) dataset. MethodsBased on clinical data from 421 AD outpatients with agitation or psychotic symptoms needed interventional treatment enrolled in the CATIE-AD, we conducted logistic regression analyses to examine the relationships between each symptomatic cluster and three psychosocial (marital status, residence, and caregivers' burden) and nine clinico-demographic (age, gender, education year, general cognition, activity of daily living [ADL], general medical health, race, and intake of anti-dementia drugs or psychotropics) factors. ResultsWhile no factor contributed to aggressiveness, psychosis was associated with several clinico-demographic factors: female gender, non-Caucasian race, and lower cognitive function. Apathy/eating problems was associated with more severe caregiver burden, living in one's own home, lower ADL level, and male gender, while emotion/disinhibition was predicted by more severe caregiver burden, lower education level, not-married status, and younger age. ConclusionsAmong the four NPS clusters, apathy/eating problems and emotion/disinhibition were associated with psychosocial as well as clinico-demographic factors in AD patients with psychotic symptoms or agitation needed interventional treatment. Copyright (c) 2016 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据